Posts Tagged ‘trudeau institute’

Monday, January 29, 2024

Adirondack-area nonprofits welcome new hires

William W. Reiley, Ph.D.

Several Adirondack-area nonprofit organizations have recently announced a lineup of new leadership, staff, board members, and trustees. See below for details on these announcements by the following establishments, Adirondack Foundation, Adirondack Council, the Trudeau Institute, The Hyde Collection, and Silver Bay YMCA.

 

Trudeau Institute appoints William Reiley as new head of scientific research institute

Saranac Lake, NY —The Trudeau Institute Board of Trustees has named William W. Reiley, Ph.D., the next president, director and chief executive officer of Trudeau Institute.

Dr. Reiley is replacing William Chapin, who has announced plans to step down on Feb. 1. Chapin has accepted a new position at another organization in the Tri-Lakes region.

Dr. Reiley, who has served in a range of positions at Trudeau since 2006, is currently chief scientific officer at the research institute, as well as a principal investigator and head of TICRO Bioservices, the contract research unit he helped launch in 2011.

» Continue Reading.


Monday, November 27, 2023

Trudeau Institute Education Program receives over $100,000 in grants

Kailey Kipping (left) and Anna Dumas (right) participated in Trudeau Institute's 2023 Summer Undergraduate Research Program.
Over $100,000 from Hearst Foundations, regional businesses help college students gain hands-on lab experience

Saranac Lake, NY—A $100,000 grant from Hearst Foundations is providing undergraduate students the opportunity to work with Trudeau Institute mentors while burnishing their prospects for graduate training programs and research positions.

Casella Waste and Stewarts Shops also provided grants to Trudeau Institute’s 10-week  Summer Undergraduate Research Program (SURP), continuing their past support to a program that has provided many college students with their first experience in a biomedical research lab. The grants support the program through 2024. » Continue Reading.


Tuesday, February 21, 2023

Trudeau Institute Wins $45,000 COVID Research Grant

Trudeau Institute

Saranac Lake, NY —Trudeau Institute will continue work to help its global partners develop vaccines and treatments for future COVID-19 variants, as well as prepare for outbreaks of other pandemics, through a grant funded by the F.M. Kirby Foundation.

The $45,000 grant has been awarded to Dr. William Reiley’s group to further characterize a recently identified mouse strain in his lab which is highly susceptible to SARS-CoV-2 infection. While existing mouse models have aided scientists in the development of vaccines and treatments against COVID-19, those models do not accurately depict acute life threatening COVID-19 disease as seen in humans, nor lasting effects seen in COVID-19 “long-haulers”.

“Our existing model is just too limited,” Dr. Reiley said. “Because of this, researchers have been hampered in their ability to understand the immune responses as they relate to control of virus replication, the viral dysregulation of the immune response, identify biomarkers of disease, and interrogate novel therapeutic targets.”

» Continue Reading.


Wednesday, February 1, 2023

Adirondack area organizations welcome new hires

Several Adirondack area organizations recently welcomed an allotment of new staff, including Champlain Area Trails (CATS), the Adirondack Park Agency (APA), The Hyde Collection, Silver Bay YMCA, and the Trudeau Institute.

Trudeau Institute President Atsuo Kuki Leaves Position, Chief Administrative Officer William Chapin named interim director

Saranac Lake—Atsuo Kuki has stepped away from his role as president and director of Trudeau Institute, after serving in the role for six years.

Chief Administrative Officer William Chapin, a 9-year Trudeau veteran, has been appointed the Institute‘s interim director.

» Continue Reading.


Sunday, September 4, 2022

Trudeau Institute, Ampersand Biosciences receive $596,519 grant for COVID research

SARANAC LAKE—Trudeau Institute and Ampersand Biosciences have received a $596,519 grant from the National Institutes of Health to develop tests that help COVID-19 researchers assess the effectiveness of new vaccines under development.

As part of the two-year Small Business Innovative Research (SBIR) grant, which will begin in September, Trudeau will produce monoclonal antibodies for Ampersand. In turn, Ampersand will include those antibodies in tests—or reagents—it produces for use by immunology researchers.

» Continue Reading.


Thursday, April 7, 2022

Trudeau Institute research highlighted in two COVID-19 studies for the federal government

coronavirusTrudeau Institute researchers played a key role in confirming the effectiveness of two approaches to fighting the novel coronavirus, according to a pair of papers published this winter.

Both projects relied on pre-clinical studies carried out at Trudeau on behalf of the Walter Reed Army Institute of Research (WRAIR), which developed the vaccine and treatment. One, which tested a new COVID-19 vaccine, was published in Cell Reports. The other, which tested a monoclonal antibody treatment aimed at infected individuals, was published in Nature Immunology.

WRAIR is a leading researcher of diseases such as malaria, HIV/AIDS, Ebola and dengue. It relied on Trudeau’s laboratory expertise to verify the effectiveness of the vaccine and treatment before moving to clinical trials.

“We have really extensive experience and knowledge of how to work with pathogens,” said William Reiley, Ph.D., head of research services at Trudeau. “Since the start of the coronavirus epidemic, we’ve been developing models to conduct preclinical, early developmental stage testing of vaccines, therapeutics and monoclonal antibodies.”

» Continue Reading.


Wednesday, February 24, 2021

Trudeau to accelerate research on COVID and tick-borne illness

TrudeauTrudeau Institute’s efforts to combat COVID-19 and tick-borne illnesses have received a $150,000 boost from the Cloudsplitter Foundation.

The gift from Cloudsplitter, which supports organizations dedicated to improving the environment, economies and lives of people in the Adirondacks, will support a new lab established by Trudeau in 2020.

» Continue Reading.


Wednesday, November 11, 2020

Trudeau Institute Fellow Takes Lead Role In Covid-19 Vaccine Trial

Trudeau Institute Fellow Dr. Stephen Thomas has been named lead principal investigator for Pfizer/BioNTech’s phase 3 clinical trial for a COVID-19 vaccine candidate.

On Monday, those companies announced early tests showing that the vaccine was more than 90 percent effective in preventing COVID-19.

Thomas, the chief of infectious disease for SUNY Upstate Medical University in Syracuse, became Trudeau’s first fellow in 2018. He has worked closely with the Institute on projects targeting Zika virus and other emerging infectious diseases and was co-organizer of the Institute’s 2018 Global Health Summit.

In his role as lead principal investigator, Thomas will assist Pfizer and BioNTech as the companies share trial results with regulatory agencies.

» Continue Reading.


Sunday, August 2, 2020

Leading Harvard immunologist discusses COVID-19 vaccine at Trudeau

Professor Barry Bloom delivers annual Steinman lecture, connects TB lessons to work today

A leading global health expert said last week that researchers know they can create a vaccine to protect against COVID-19, but it’s still too soon to predict how effective the first vaccines will be.

Dr. Barry Bloom, a renowned immunologist who has spent his career easing the impact of tuberculosis and leprosy on developing nations, was at the Trudeau Institute on July 27 to deliver the annual Ralph M. Steinman Memorial Lecture. Trudeau named Bloom an honorary trustee at the event. A video of Bloom’s presentation can be found here.

» Continue Reading.



Wait! Before you go:

Catch up on all your Adirondack
news, delivered weekly to your inbox